Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT07158853
- Status
- Recruiting
Conditions
- Buprenorphine
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial Direct Current Stimulation (tDCS) — DEVICEWe will deliver 2-mA tDCS current intensity during a 30 minute stimulation period (including a 30-second ramp-up and 30-second ramp-down period) to the dorsolateral prefrontal cortex. Electrodes will be fixed on marked locations based on the 10-20 EEG system. Anodal stimulating electrode will be over the left DLPFC (F3) and cathodal electrode over the right DLPFC (F4).
- Sham Stimulation — DEVICEelectrodes will have the same montage as active tDCS (F3/F4), but current will be ramped down after the initial 30 seconds ramp-up period. Thus, participants will feel the initial sensation associated with tDCS but will receive no active current for the rest of the stimulation period.
Study Details
The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals under buprenorphine maintenance treatment for OUD (bOUD).
Key Dates
- Start date
- Feb 4, 2026
- Status verified
- Feb 2026
- Primary completion
- Aug 1, 2026
- Completion
- Aug 1, 2026
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: tDCSAll intervention sessions will use the Soterix Mini-CT Remote tDCS device
- Placebo Comparator: Sham Electrodes
Primary Outcome Measure
tDCS effect on circuit-based target engagement of a prefrontal-incentive salience network [ Time Frame: immediately after the intervention ]
Central Contacts
- Clarista Berg952-444-0137
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 |
Find similar trials in Minneapolis, MN
By research site
Related Studies
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Using Facebook to Support Opioid Recovery Among American Indian WomenRecruiting · Mayo Clinic · Rochester, Minnesota
- Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.PHASE4 · Recruiting · Yale University · Oakland, California
- Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use DisorderRecruiting · Spark Biomedical, Inc. · Center City, Minnesota